Deadly infectious diseases such as Ebola: The parachute paradigm

Clinical Microbiology and Infection

Volumn 21, Issue 5, 2015, Pages 389-390

  Lagier, J C ^a   Raoult, D ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Ebola; Parachute paradigm; Randomized controlled trial

Indexed keywords

EBOLA HEMORRHAGIC FEVER; ECOSYSTEM; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE PERSONNEL; HUMAN; MORTALITY; PRIORITY JOURNAL; CLINICAL TRIAL (TOPIC); COMMUNICABLE DISEASES;

CLINICAL TRIALS AS TOPIC; COMMUNICABLE DISEASES; HUMANS;

EID: 84930517281     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.02.027     Document Type: Editorial

References (5)

1. Fournier P.E., Thuny F., Richet H., Lepidi H., Casalta J.P., Arzouni J.P., et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 2010, 51:131-140.
2. Watt G., Pachirat O., Baggett H.C., Maloney S.A., Lulitanond V., Raoult D., et al. Infective endocarditis in northeastern Thailand. Emerg Infect Dis 2014, 20:473-476.
3. Smith G.C., Pell J.P. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 2003, 327(7429):1459-1461.
4. Cox E., Borio L., Temple R. Evaluating Ebola therapies-the case for RCTs. NEngl J Med 2014, 371:2350-2351.
5. Raoult D. Chronic Q fever: expert opinion versus literature analysis and consensus. JInfect 2012, 65:102-108.